Article Text

Download PDFPDF

MMP12 and reduced risk of COPD
  1. A Pillai
  1. North Bristol Lung Centre, Bristol
  1. Correspondence to Anilkumar Pillai, Gloucestershire Royal Hospital, UK; anilkumarpillai{at}

Statistics from

Not all smokers develop chronic obstructive pulmonary disease (COPD), and not everyone with COPD has the same rate of decline of lung function. In this study the authors hypothesised that matrix metalloproteinase 12 (MMP12) variants have a role in lung function and are risk factors for COPD. MMP12 is produced by macrophages, one of the main inflammatory cells associated with smoking.

Seven different cohorts that included two cohorts of children with asthma, one birth cohort and two cohorts of adults with and without COPD were tested for an association between single nucleotide polymorphisms (SNPs) in the MMP12 gene and force expiratory volume in 1 s (FEV1).

The minor allele of a functional variant of MMP12 was shown to have a positive association with FEV1 in children with asthma and in adult smokers with COPD or at risk of COPD. The expression of this allele had a beneficial effect on lung function and was associated with a reduced risk of COPD in adult smokers.

These findings lend weight to the ‘Dutch hypothesis’ of asthma and COPD. The fact that the cohorts were diverse and many of them were on various medications may explain why the association was significant in combined analyses of the cohorts but not so in the individual cohorts. Nevertheless this study adds more weight to the importance of a genetic element in the development of COPD.

▶ Hunninghake GM, Cho MH,Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009;361:2599–608.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.